Meditronics (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 27 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.80 Cr
as on 16-11-2024
- Revenue 431.96%
(FY 2023)
- Profit 352.39%
(FY 2023)
- Ebitda -17277.88%
(FY 2023)
- Net Worth 5.26%
(FY 2023)
- Total Assets 74.00%
(FY 2023)
About Meditronics (India)
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹5.80 Cr.
Seema Gandhi and Sunil Gandhi serve as directors at the Company.
- CIN/LLPIN
U24239DL1997PTC085706
- Company No.
085706
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Mar 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Meditronics (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Seema Gandhi  | Director | 20-Mar-2018 | Current |
| Sunil Gandhi | Director | 25-Oct-2004 | Current |
Financial Performance and Corporate Structure Insights of Meditronics (India).
Meditronics (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 431.96% increase. The company also saw a substantial improvement in profitability, with a 352.39% increase in profit. The company's net worth moved up by a moderate rise of 5.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Meditronics (India)?
In 2023, Meditronics (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sereno Infra Ventures Private LimitedActive 1 year 3 monthsSeema Gandhi and Sunil Gandhi are mutual person
- S G Developers Private LimitedActive 16 years 6 months
Seema Gandhi and Sunil Gandhi are mutual person
- Venkteshwara Buildtech Private LimitedActive 13 years 11 months
Seema Gandhi and Sunil Gandhi are mutual person
- Shubhankar Exim Private LimitedActive 16 years 6 months
Seema Gandhi and Sunil Gandhi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Jun 2022 | ₹5.00 Cr | Open |
Bank Of Punjab Ltd Creation Date: 14 Feb 2005 | ₹8.00 M | Open |
How Many Employees Work at Meditronics (India)?
Unlock and access historical data on people associated with Meditronics (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Meditronics (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meditronics (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
